High Quality Tranexamic Acid White Powder CAS 1197-18-8
Product Name: APROTININ BOVINE LUNG
CAS No.:9087-70-1
MF: C284H432N84O79S7
EINECS No.:232-994-9
Place of Origin: Jiangxi, China
Product Details
We use advanced production technology and equipment, perfect product quality assurance system, and professional and rigorous technical personnel to provide strong guarantee for the quality of Cas No. 61-76-7, Cas No. 105889-45-0, CAS 2971-90-6. We will continue to adhere to the principle of 'honest management' and implement the strategy of focusing on enterprise management internally and expanding international market externally. We will gradually establish a sound R&D, design, manufacturing, sales and customer service system. We keep moving forward since we have a huge corporate cohesion and a humanized corporate culture, adhering to the concept of integrity, pragmatism, and innovation.
Product Description
The Aprotinin BP USP CAS 9087-70-1 is a polypeptide extracted and purified from bovine pancreas or bovine lung and having proteolytic activity. It is a substance that can combine with an enzyme to reduce the decomposition rate of the substrate acting by the enzyme, and has protein properties. It belongs to protease preparations, which can inhibit trypsin and chymotrypsin, prevent the activation of other active proteases in the pancreas and the self-activation of trypsinogen. The Aprotinin BP USP is clinically used to prevent and treat acute pancreatitis, hemorrhage caused by fibrinolysis and disseminated intravascular coagulation, and can also be used for anti-shock therapy.
The corporate keeps towards the operation concept 'scientific administration, superior quality and performance primacy, client supreme for High Quality Tranexamic Acid White Powder CAS 1197-18-8. We have devoted ourselves to research in the technical field, and independently developed many products, which have been widely used and recognized in the industry. Looking to the future, in order to further consolidate the foundation of enterprise development, we will focus on reforming the organizational culture and rebuilding the appropriate framework.
